Biotech

A key lawmaker who often disagrees with Governor Jim Doyle on embryonic stem cell research said Wednesday that he saw nothing inappropriate about the governor's use of an executive order as an instrument to fund the recruiting of stem cell companies. Meanwhile, the executive order, signed...

QBI Life Sciences today announced the release of a product that will allow drug researchers to better work with difficult-to-handle membrane proteins, and perhaps improve the cost effectiveness of drug discovery....

Madison, Wis. — One of the more hopeful promises of stem cells is the creation of new organs, grown to meet the medical demand that is not being met by organ donation. But experts are concerned that high hopes could lead to backlash: among patients...

Wauwatosa, Wis. - With the goal of capturing 10 percent of the stem cell technology market by 2015, Governor Jim Doyle signed an executive order directing the Department of Commerce to spend at least $5 million in economic development money to recruit new stem cell...

With BIO 2006 still fresh in our minds, Mike Rosen comments on how it was a big success in many ways, but the challenge now for Midwesterners is how to leverage this momentum from the event into creating a major Midwest life science cluster. One...